Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$75.66
0.440.58%
At close: Nov 14, 4:00 PM EST
$75.66
N/A
After Hours: Nov 14, 4:00 PM EST
Comments
Loading...
Solventum Analyst Ratings and Price Targets | NYSE:SOLV | Benzinga
Solventum Corp has a consensus price target of $84.67 based on the ratings of 14 analysts. The high is $103 issued by Morgan Stanley on July 15, 2025. The low is $71 issued by Goldman Sachs on March 3, 2025. The 3 most-recent analyst ratings were released by UBS, Piper Sandler, and UBS on November 10, 2025, November 7, 2025, and October 1, 2025, respectively. With an average price target of $84.67 between UBS, Piper Sandler, and UBS, there's an implied 11.90% upside for Solventum Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
UBS
Piper Sandler
Wells Fargo
Jefferies
Morgan Stanley
1calculated from analyst ratings
Analyst Ratings for Solventum
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/10/2025 | 4.41% | UBS | $77 → $79 | Maintains | Neutral | |||
11/07/2025 | 29.53% | Piper Sandler | $94 → $98 | Maintains | Overweight | |||
10/01/2025 | 1.77% | UBS | → $77 | Initiates | → Neutral | |||
09/15/2025 | 8.38% | Wells Fargo | $79 → $82 | Maintains | Equal-Weight | |||
09/11/2025 | 5.74% | Jefferies | → $80 | Initiates | → Hold | |||
08/08/2025 | 4.41% | Wells Fargo | $75 → $79 | Maintains | Equal-Weight | |||
08/08/2025 | 24.24% | Piper Sandler | $87 → $94 | Maintains | Overweight | |||
07/15/2025 | 36.14% | Morgan Stanley | $80 → $103 | Upgrade | Equal-Weight → Overweight | |||
07/01/2025 | — | Argus Research | — | Upgrade | Hold → Buy | |||
06/06/2025 | — | Keybanc | — | Initiates | → Sector Weight | |||
05/19/2025 | 14.99% | Piper Sandler | $78 → $87 | Upgrade | Neutral → Overweight | |||
05/09/2025 | 3.09% | Piper Sandler | $80 → $78 | Maintains | Neutral | |||
04/30/2025 | 5.74% | Piper Sandler | $84 → $80 | Maintains | Neutral | |||
03/05/2025 | 5.74% | Morgan Stanley | $73 → $80 | Maintains | Equal-Weight | |||
03/03/2025 | 8.38% | Mizuho | $70 → $82 | Maintains | Neutral | |||
03/03/2025 | -6.16% | Goldman Sachs | $63 → $71 | Maintains | Sell | |||
02/28/2025 | -0.87% | Wells Fargo | $73 → $75 | Maintains | Equal-Weight | |||
02/28/2025 | 11.02% | Piper Sandler | $75 → $84 | Maintains | Neutral | |||
02/26/2025 | 12.34% | B of A Securities | $80 → $85 | Maintains | Neutral | |||
12/04/2024 | -7.48% | Mizuho | → $70 | Initiates | → Neutral | |||
11/11/2024 | -3.52% | Morgan Stanley | $60 → $73 | Maintains | Equal-Weight | |||
11/08/2024 | -0.87% | Piper Sandler | $71 → $75 | Maintains | Neutral | |||
10/08/2024 | 8.38% | Stifel | → $82 | Initiates | → Buy | |||
10/07/2024 | -6.16% | Piper Sandler | → $71 | Initiates | → Neutral | |||
09/26/2024 | — | Wolfe Research | — | Initiates | → Peer Perform | |||
09/05/2024 | — | BTIG | — | Initiates | → Neutral | |||
08/12/2024 | -28.63% | Goldman Sachs | $48 → $54 | Maintains | Sell | |||
08/09/2024 | -15.41% | Wells Fargo | $69 → $64 | Maintains | Equal-Weight | |||
07/15/2024 | -27.31% | Morgan Stanley | $70 → $55 | Maintains | Equal-Weight | |||
07/10/2024 | -36.56% | Goldman Sachs | $54 → $48 | Maintains | Sell | |||
06/25/2024 | -20.7% | B of A Securities | $70 → $60 | Maintains | Neutral | |||
05/30/2024 | -28.63% | Goldman Sachs | → $54 | Initiates | → Sell | |||
05/10/2024 | -7.48% | B of A Securities | → $70 | Initiates | → Neutral | |||
04/10/2024 | -7.48% | Morgan Stanley | → $70 | Initiates | → Equal-Weight | |||
04/08/2024 | -8.8% | Wells Fargo | → $69 | Initiates | → Equal-Weight | |||
04/02/2024 | — | Edward Jones | — | Initiates | → Hold |
FAQ
What is the target price for Solventum (SOLV) stock?
The latest price target for Solventum (NYSE:SOLV) was reported by UBS on November 10, 2025. The analyst firm set a price target for $79.00 expecting SOLV to rise to within 12 months (a possible 4.41% upside). 20 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Solventum (SOLV)?
The latest analyst rating for Solventum (NYSE:SOLV) was provided by UBS, and Solventum maintained their neutral rating.
When was the last upgrade for Solventum (SOLV)?
The last upgrade for Solventum Corp happened on July 15, 2025 when Morgan Stanley raised their price target to $103. Morgan Stanley previously had an equal-weight for Solventum Corp.
When was the last downgrade for Solventum (SOLV)?
There is no last downgrade for Solventum.
When is the next analyst rating going to be posted or updated for Solventum (SOLV)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Solventum, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Solventum was filed on November 10, 2025 so you should expect the next rating to be made available sometime around November 10, 2026.
Is the Analyst Rating Solventum (SOLV) correct?
While ratings are subjective and will change, the latest Solventum (SOLV) rating was a maintained with a price target of $77.00 to $79.00. The current price Solventum (SOLV) is trading at is $75.66, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
